Health Issues and Immunological Assessment Related to Wuhan's COVID-19 Survivors: A Multicenter Follow-Up Study

Frontiers in Medicine

Qing Zhang¹  Lingjie Zhang²  Amy Bryant³  Li Wei⁴  Fei Wang⁴  Suihuai Guo⁵  Xianglin Yuan⁶  Guangyuan Hu⁶  Qi Mei⁶  Yang Yang⁷  Jian Li⁸  Christian Kurts⁸ 

[1] Covid-19 Rehabilitation Center, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China;Department of Anesthesiology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, China;Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Meridian, ID, United States;Department of Chinese Medicine, Wuhan No.1 Hospital, Huazhong University of Science and Technology, Wuhan, China;Department of Intensive Care Unit, Wuhan Wuchang Hospital, Wuhan, China;Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China;Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China;Institute of Experimental Immunology, University Clinic of Rheinische Friedrich-Wilhelms-University, Bonn, Germany;

关键词: post-COVID-19;    SARS-CoV-2;    mortality;    hospital discharge;    post-COVID-19 sequela;    physical and psychological symptoms;    antibody test;    IgG and IgM;   

DOI  :  10.3389/fmed.2021.617689

来源: Frontiers

【 授权许可】

CC BY